Podcasts

Omega-3 fatty acids used to treat patients with dysglycemia in the ORIGIN trial failed to reduce cardiovascular death or ischemic events. Follow-up was 6 years.

In this podcast, the chair of the International Antiviral Society USA tells why it now advises immediate antiretroviral treatment for everyone diagnosed with HIV infection.

Achieving sustained reductions of hyperlipidemia and blood pressure in a patient with diabetes is not impossible, but it's a challenge. A new study comparing two health systems shows which factors increase the odds of success.

The popular media recently took a look at the connection between systemic inflammation and the many human diseases it’s responsible for. A lengthy article in the Wall Street Journal focused on the role of daily diet in the development and modulation of inflammation and noted the clinical use of biomarker C-reactive protein to measure inflammation levels. Harvard cardiologist Christopher Cannon offered tips on eating to beat inflammation and shed pounds at the same time from his new book titled The Complete Idiot’s Guide to the Anti-Inflammation Diet. Alarming health news paired with a new book on diet can create a perfect storm of questions from you patients.

Ticagrelor is the newest P2Y12 inhibitor approved to treat patients with unstable angina or non-ST elevation myocardial infarction. AHA/ACC guideline update.

Far too many HIV-positive patients get that bad news after their very first HIV test, nationwide data show. Hear a CDC expert tell why primary care doctors are key to improving HIV testing rates and saving lives.

Some say chlorthalidone is superior to hydrochlorothiazide and should be used as first-line therapy in hypertension. A compelling case can be made for resurrecting this venerable drug.

Novel anticoagulants (dabigatran, rivaroxaban, apixaban) are gaining wide acceptance over warfarin, for their simplicity of use and proven efficacy.

Statin medications were associated with significant tiredness and exertional fatigue in men and women without cardiovascular disease or diabetes.

Azithromycin has been linked to sudden cardiac death in patients with cardiovascular disease that require an antibiotic.